Trial Profile
Multiple-dose Pharmacokinetics and Tolerability of "SYN006 HFA MDI" (Budesonide 180ug + Procaterol Hydrochloride 10ug/Dose HFA MDI) Administered Orally to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs Budesonide/procaterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Intech Biopharm
- 24 Jun 2014 New trial record